Nishizaka MK - Search Results

1

Plasma aldosterone is related to severity of obstructive sleep apnea in subjects with resistant hypertension.

Pratt-Ubunama MN, Nishizaka MK, Boedefeld RL, Cofield SS, Harding SM, Calhoun DA. Pratt-Ubunama MN, et al. Among authors: nishizaka mk. Chest. 2007 Feb;131(2):453-9. doi: 10.1378/chest.06-1442. Chest. 2007. PMID: 17296647

2

Efficacy of low-dose spironolactone in subjects with resistant hypertension.

Nishizaka MK, Zaman MA, Calhoun DA. Nishizaka MK, et al. Am J Hypertens. 2003 Nov;16(11 Pt 1):925-30. doi: 10.1016/s0895-7061(03)01032-x. Am J Hypertens. 2003. PMID: 14573330 Clinical Trial.

3

Resistant hypertension.

Calhoun DA, Zaman MA, Nishizaka MK. Calhoun DA, et al. Among authors: nishizaka mk. Curr Hypertens Rep. 2002 Jun;4(3):221-8. doi: 10.1007/s11906-002-0011-8. Curr Hypertens Rep. 2002. PMID: 12003705 Review.

4

Hyperaldosteronism among black and white subjects with resistant hypertension.

Calhoun DA, Nishizaka MK, Zaman MA, Thakkar RB, Weissmann P. Calhoun DA, et al. Among authors: nishizaka mk. Hypertension. 2002 Dec;40(6):892-6. doi: 10.1161/01.hyp.0000040261.30455.b6. Hypertension. 2002. PMID: 12468575 Clinical Trial.

5

Aldosterone excretion among subjects with resistant hypertension and symptoms of sleep apnea.

Calhoun DA, Nishizaka MK, Zaman MA, Harding SM. Calhoun DA, et al. Among authors: nishizaka mk. Chest. 2004 Jan;125(1):112-7. doi: 10.1378/chest.125.1.112. Chest. 2004. PMID: 14718429

6

Validity of plasma aldosterone-to-renin activity ratio in African American and white subjects with resistant hypertension.

Nishizaka MK, Pratt-Ubunama M, Zaman MA, Cofield S, Calhoun DA. Nishizaka MK, et al. Am J Hypertens. 2005 Jun;18(6):805-12. doi: 10.1016/j.amjhyper.2005.01.002. Am J Hypertens. 2005. PMID: 15925740

7

The role of aldosterone antagonists in the management of resistant hypertension.

Nishizaka MK, Calhoun DA. Nishizaka MK, et al. Curr Hypertens Rep. 2005 Oct;7(5):343-7. doi: 10.1007/s11906-005-0067-3. Curr Hypertens Rep. 2005. PMID: 16157075 Review.

8

Aldosterone excess and resistance to 24-h blood pressure control.

Pimenta E, Gaddam KK, Pratt-Ubunama MN, Nishizaka MK, Cofield SS, Oparil S, Calhoun DA. Pimenta E, et al. Among authors: nishizaka mk. J Hypertens. 2007 Oct;25(10):2131-7. doi: 10.1097/HJH.0b013e3282a9be30. J Hypertens. 2007. PMID: 17885558

9

Relation of dietary salt and aldosterone to urinary protein excretion in subjects with resistant hypertension.

Pimenta E, Gaddam KK, Pratt-Ubunama MN, Nishizaka MK, Aban I, Oparil S, Calhoun DA. Pimenta E, et al. Among authors: nishizaka mk. Hypertension. 2008 Feb;51(2):339-44. doi: 10.1161/HYPERTENSIONAHA.107.100701. Epub 2007 Dec 17. Hypertension. 2008. PMID: 18086955

10

Characterization of resistant hypertension: association between resistant hypertension, aldosterone, and persistent intravascular volume expansion.

Gaddam KK, Nishizaka MK, Pratt-Ubunama MN, Pimenta E, Aban I, Oparil S, Calhoun DA. Gaddam KK, et al. Among authors: nishizaka mk. Arch Intern Med. 2008 Jun 9;168(11):1159-64. doi: 10.1001/archinte.168.11.1159. Arch Intern Med. 2008. PMID: 18541823 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

35 results

Search Page